Form D · Biotechnology
VitalPoint Technologies, Inc.
Houston, TX · CIK 0001989795
Offering snapshot reported Aug 11, 2023 · SEC filing
- Reported sold
- Yet to sell Offering amount: $300K
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $2.5K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 11, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-489489
$50,000 at $0.25 with 1.00 warrant at $0.50, $250,000 at $.50 with warrant at $1.00
The Company is not offering any sales commissions or finders' fees at this time.
Source: Form D, filed Aug 11, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Cook | Executive |
| Robert Yrshus | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5318 Westlayan St. #152
Houston, TX, 77005
Houston, TX, 77005